TRANSCODE THERAPEUTICS, INC. Current Assets
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Current Assets of $10.64 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $10.64M.
- 2026-03-31: Assets, Current $16.75M.
- 2025-12-31: Assets, Current $21.98M.
- 2025-09-30: Assets, Current $4.75M.
| Period end | Assets, Current |
|---|---|
| 2026-06-30 | $10.64M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $16.75M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $21.98M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $4.75M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $8.24M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $13.04M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $7.09M 10-K · filed 2026-04-15 |
| 2024-09-30 | $3.61M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $4.39M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $6.71M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $4.46M 10-K · filed 2025-04-15 |
| 2023-09-30 | $9.37M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $4.89M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $4.35M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $7.38M 10-K · filed 2024-04-01 |
| 2022-09-30 | $11.57M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $13.92M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $18.63M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $22.73M 10-K · filed 2023-03-31 |
| 2021-09-30 | $25.20M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $540.22K 10-Q · filed 2021-08-23 |
| 2020-12-31 | $831.22K 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |